Pub Date : 2025-06-13DOI: 10.1016/j.jhqr.2025.101147
S. Kaniyil , P. Pavithran , A.K. Arun Krishna , M.C. Rajesh
Background and objectives
Enhancing patient safety in Anaesthesia relies significantly on critical incident reporting and analysis. We did an online web-based survey aiming to evaluate the awareness and practices of our anaesthesiologists on critical incident reporting in India.
Materials and methods
A validated questionnaire was disseminated via online social media platforms to evaluate the awareness and current practices of anaesthesiologists on incident reporting and analysis. Timely reminders were issued to enhance response rates, and data analyzed upon receipt of sufficient responses.
Results
Among the 506 responses received, 60% reported having a workplace incident reporting system. Despite high awareness, a significant majority expressed reluctance to report incidents, citing the fear of blame and shame as a deterrent. The most frequently reported incidents included cardiac arrest and drug errors. Identified contributing factors included inadequate staffing, communication gaps, prolonged work hours, a stressful work environment, and the absence of institutional protocols.
Conclusions
Despite a notable level of awareness regarding critical incident reporting among our anaesthesiologists, apprehensions related to blame and finger-pointing hinder the reporting process. As a uniform reporting system is lacking, formulating a national guideline, and establishing a standard reporting system is the need of the hour.
{"title":"Results of a survey to evaluate awareness and practices of critical incident reported by anaesthesiologists","authors":"S. Kaniyil , P. Pavithran , A.K. Arun Krishna , M.C. Rajesh","doi":"10.1016/j.jhqr.2025.101147","DOIUrl":"10.1016/j.jhqr.2025.101147","url":null,"abstract":"<div><h3>Background and objectives</h3><div>Enhancing patient safety in Anaesthesia relies significantly on critical incident reporting and analysis. We did an online web-based survey aiming to evaluate the awareness and practices of our anaesthesiologists on critical incident reporting in India.</div></div><div><h3>Materials and methods</h3><div>A validated questionnaire was disseminated via online social media platforms to evaluate the awareness and current practices of anaesthesiologists on incident reporting and analysis. Timely reminders were issued to enhance response rates, and data analyzed upon receipt of sufficient responses.</div></div><div><h3>Results</h3><div>Among the 506 responses received, 60% reported having a workplace incident reporting system. Despite high awareness, a significant majority expressed reluctance to report incidents, citing the fear of blame and shame as a deterrent. The most frequently reported incidents included cardiac arrest and drug errors. Identified contributing factors included inadequate staffing, communication gaps, prolonged work hours, a stressful work environment, and the absence of institutional protocols.</div></div><div><h3>Conclusions</h3><div>Despite a notable level of awareness regarding critical incident reporting among our anaesthesiologists, apprehensions related to blame and finger-pointing hinder the reporting process. As a uniform reporting system is lacking, formulating a national guideline, and establishing a standard reporting system is the need of the hour.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101147"},"PeriodicalIF":1.1,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144271165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-09DOI: 10.1016/j.jhqr.2025.101146
P. Cárdenas-Soriano , V.S.H. Múgica , P. Blanco-Hernández , M. Gil-López , G. Rodríguez-Caravaca , A.M. Pedraza-Flechas
Objective
To assess the prevalence of Healthcare-Associated Infections (HAIs) acquired during hospitalization in a long-term care (LTC) hospital during three periods and identify associated factors.
Methods
An observational, cross-sectional study had been conducted in 2019, 2021, and 2023 that included 380 patients. Data collected encompassed demographics, presence of risk factors (pressure sores, catheters, surgery), and HAIs acquired in the current hospitalization. Global and per location HAI was determined, and bivariate and a multiple logistic regression model was constructed to explore the association between the studied variables and infection.
Results
The median age varied depending on the year of the survey between 77 and 80.5 years, and the proportion of female patients increased each edition. Length of stay peaked in 2021 (43.5 days), and risk factors in 2023. HAIs prevalences were 8.4% (2019), 10.7% (2021), and 5.6% (2023). Respiratory tract infection was the most frequent globally (34.4%), in 2019 (35.7%) and 2023 (50.0%), followed by urinary tract infection. Globally, HAI and any risk factor (OR: 3.8, 95% CI: 1.6–8.8), and pressure sores (OR: 2.4, 95% CI: 1.1–5.2) were associated, this last remained after adjustment (OR: 16.0, 95% CI: 2.5–104.9).
Conclusions
LTC hospitals pose a risk for HAI. Further research on associated factors and preventive strategies is crucial to improve care in this sector.
{"title":"Healthcare-associated infections in a long-term care hospital: A three-year point-prevalence study","authors":"P. Cárdenas-Soriano , V.S.H. Múgica , P. Blanco-Hernández , M. Gil-López , G. Rodríguez-Caravaca , A.M. Pedraza-Flechas","doi":"10.1016/j.jhqr.2025.101146","DOIUrl":"10.1016/j.jhqr.2025.101146","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the prevalence of Healthcare-Associated Infections (HAIs) acquired during hospitalization in a long-term care (LTC) hospital during three periods and identify associated factors.</div></div><div><h3>Methods</h3><div>An observational, cross-sectional study had been conducted in 2019, 2021, and 2023 that included 380 patients. Data collected encompassed demographics, presence of risk factors (pressure sores, catheters, surgery), and HAIs acquired in the current hospitalization. Global and per location HAI was determined, and bivariate and a multiple logistic regression model was constructed to explore the association between the studied variables and infection.</div></div><div><h3>Results</h3><div>The median age varied depending on the year of the survey between 77 and 80.5 years, and the proportion of female patients increased each edition. Length of stay peaked in 2021 (43.5 days), and risk factors in 2023. HAIs prevalences were 8.4% (2019), 10.7% (2021), and 5.6% (2023). Respiratory tract infection was the most frequent globally (34.4%), in 2019 (35.7%) and 2023 (50.0%), followed by urinary tract infection. Globally, HAI and any risk factor (OR: 3.8, 95% CI: 1.6–8.8), and pressure sores (OR: 2.4, 95% CI: 1.1–5.2) were associated, this last remained after adjustment (OR: 16.0, 95% CI: 2.5–104.9).</div></div><div><h3>Conclusions</h3><div>LTC hospitals pose a risk for HAI. Further research on associated factors and preventive strategies is crucial to improve care in this sector.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101146"},"PeriodicalIF":1.1,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-09DOI: 10.1016/j.jhqr.2025.101148
M. Vaccaro , G. Polito , G. Bagaglini , M. Capuozzo , R. Langella , E. Nava , A. Zovi , F. Ferrara
Background
Biosimilar drugs represent a valuable opportunity for healthcare systems worldwide, offering substantial cost savings while ensuring equivalent efficacy and safety in treating chronic conditions. These savings can be reinvested in ongoing medical innovation.
Methods
An investigation was carried out to evaluate the utilization of key biologic therapies across various clinical indications within two Italian healthcare institutions: Asl Napoli 3 Sud and Policlinico Umberto I in Rome. Information regarding consumption and expenditure was extracted from institutional databases. A comparison with figures from 2021 was conducted to detect any growth in biosimilar adoption throughout 2022.
Results
The 2022 review demonstrated that most of the examined compounds were administered predominantly as biosimilars, with proportions nearing complete substitution, aside from some notable outliers. In particular, reluctance persisted in prescribing biosimilar adalimumab (73.8%) and etanercept (73.3%) at Asl Napoli 3 Sud, as well as erythropoietin (69.5%) and rituximab (72.8%) at Policlinico Umberto I.
Conclusion
The year-on-year comparison between 2021 and 2022 underscored a growing shift toward biosimilar prescriptions. This favorable direction indicates the likelihood of reaching full implementation soon, with meaningful advantages for the National Healthcare Service and citizens, promoting an efficient and economically viable model of care.
生物仿制药为全球医疗保健系统提供了一个宝贵的机会，在确保治疗慢性疾病的同等功效和安全性的同时，提供了大量的成本节约。这些节省下来的资金可以再投资于正在进行的医疗创新。方法开展一项调查，评估两家意大利医疗机构（那不勒斯3 Sud医院和罗马Umberto I医院）在各种临床适应症中关键生物疗法的使用情况。有关消费和支出的资料摘自机构数据库。与2021年的数据进行比较，以检测整个2022年生物仿制药采用的增长情况。结果2022年的审查表明，除了一些显著的异常值外，大多数被检查的化合物主要作为生物类似药给药，比例接近完全替代。特别是，在Asl Napoli 3 Sud，不愿开生物仿制药阿达木单抗（73.8%）和依那西普（73.3%），以及在Policlinico Umberto i，不愿开促红细胞生成素（69.5%）和利妥昔单抗（72.8%）。结论2021年和2022年的同比比较表明，越来越多的人转向开生物仿制药。这一有利的方向表明，很快就有可能全面实施，对国家医疗保健服务和公民有意义的好处，促进一种高效和经济上可行的护理模式。
{"title":"Comparison and analysis of biological drug consumption in two Italian hospital settings: Governance actions and prescribing appropriateness","authors":"M. Vaccaro , G. Polito , G. Bagaglini , M. Capuozzo , R. Langella , E. Nava , A. Zovi , F. Ferrara","doi":"10.1016/j.jhqr.2025.101148","DOIUrl":"10.1016/j.jhqr.2025.101148","url":null,"abstract":"<div><h3>Background</h3><div>Biosimilar drugs represent a valuable opportunity for healthcare systems worldwide, offering substantial cost savings while ensuring equivalent efficacy and safety in treating chronic conditions. These savings can be reinvested in ongoing medical innovation.</div></div><div><h3>Methods</h3><div>An investigation was carried out to evaluate the utilization of key biologic therapies across various clinical indications within two Italian healthcare institutions: Asl Napoli 3 Sud and Policlinico Umberto I in Rome. Information regarding consumption and expenditure was extracted from institutional databases. A comparison with figures from 2021 was conducted to detect any growth in biosimilar adoption throughout 2022.</div></div><div><h3>Results</h3><div>The 2022 review demonstrated that most of the examined compounds were administered predominantly as biosimilars, with proportions nearing complete substitution, aside from some notable outliers. In particular, reluctance persisted in prescribing biosimilar adalimumab (73.8%) and etanercept (73.3%) at Asl Napoli 3 Sud, as well as erythropoietin (69.5%) and rituximab (72.8%) at Policlinico Umberto I.</div></div><div><h3>Conclusion</h3><div>The year-on-year comparison between 2021 and 2022 underscored a growing shift toward biosimilar prescriptions. This favorable direction indicates the likelihood of reaching full implementation soon, with meaningful advantages for the National Healthcare Service and citizens, promoting an efficient and economically viable model of care.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101148"},"PeriodicalIF":1.1,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-09DOI: 10.1016/j.jhqr.2025.101149
M. Santiñà Vila , D. Juvinyà Canal
{"title":"Salutogénesis en vez de patogénesis, ¿estamos realizando la necesaria transformación del modelo de sistema de salud?","authors":"M. Santiñà Vila , D. Juvinyà Canal","doi":"10.1016/j.jhqr.2025.101149","DOIUrl":"10.1016/j.jhqr.2025.101149","url":null,"abstract":"","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101149"},"PeriodicalIF":1.1,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-30DOI: 10.1016/j.jhqr.2025.101141
A. Jain , N.D. Bhardwaj , M. Suhaib , P. Srivastava , S. Khan , S. Rawat
Background
Access to essential medicines is vital for healthcare. The National List of Essential Medicines (NLEM) 2022 serves a guide for Indian healthcare facilities in procuring and providing essential medicines at different levels of healthcare. This study aimed at assessing the compliance of essential medicines availability at a tertiary care government hospital.
Methods
This cross-sectional study was conducted over a period of 24 weeks to assess the availability of essential medicines via reviewing of documents and content analysis. One-Sample Proportion Z-Test (two-tailed) was used to statistically test the result. Z-score was calculated and statistical significance of result was checked. The compliance for various categories as per NLEM 2022 was analyzed and an overall compliance was calculated.
Results
The hospital procured 85.4% (328/384) of NLEM 2022 drugs. Based on the One-Sample Proportion Z-Test, calculated Z-score was 2.65 with 95% confidence interval which indicates the hospital's procurement rate of 85.4% is significantly higher than the expected WHO benchmark of 80%. A total of 18 NLEM sections had ≥80% compliance, with eight sections reached full compliance. However, gaps existed in sections like antidotes, diagnostic agents and dermatological medicines.
Conclusion
In comparison with earlier studies from India, the tertiary care hospital under study has shown better adherence to NLEM 2022 guidelines but there are still some gaps. By addressing the gaps, hospital can continuously improve healthcare delivery, ensure patient safety, and adapt to evolving health challenges, ultimately ensuring high-quality patient care.
{"title":"Conformance to the National List of Essential Medicines 2022 in a government tertiary care hospital","authors":"A. Jain , N.D. Bhardwaj , M. Suhaib , P. Srivastava , S. Khan , S. Rawat","doi":"10.1016/j.jhqr.2025.101141","DOIUrl":"10.1016/j.jhqr.2025.101141","url":null,"abstract":"<div><h3>Background</h3><div>Access to essential medicines is vital for healthcare. The National List of Essential Medicines (NLEM) 2022 serves a guide for Indian healthcare facilities in procuring and providing essential medicines at different levels of healthcare. This study aimed at assessing the compliance of essential medicines availability at a tertiary care government hospital.</div></div><div><h3>Methods</h3><div>This cross-sectional study was conducted over a period of 24 weeks to assess the availability of essential medicines via reviewing of documents and content analysis. One-Sample Proportion <em>Z</em>-Test (two-tailed) was used to statistically test the result. <em>Z</em>-score was calculated and statistical significance of result was checked. The compliance for various categories as per NLEM 2022 was analyzed and an overall compliance was calculated.</div></div><div><h3>Results</h3><div>The hospital procured 85.4% (328/384) of NLEM 2022 drugs. Based on the One-Sample Proportion <em>Z</em>-Test, calculated <em>Z</em>-score was 2.65 with 95% confidence interval which indicates the hospital's procurement rate of 85.4% is significantly higher than the expected WHO benchmark of 80%. A total of 18 NLEM sections had ≥80% compliance, with eight sections reached full compliance. However, gaps existed in sections like antidotes, diagnostic agents and dermatological medicines.</div></div><div><h3>Conclusion</h3><div>In comparison with earlier studies from India, the tertiary care hospital under study has shown better adherence to NLEM 2022 guidelines but there are still some gaps. By addressing the gaps, hospital can continuously improve healthcare delivery, ensure patient safety, and adapt to evolving health challenges, ultimately ensuring high-quality patient care.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101141"},"PeriodicalIF":1.1,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144170143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-20DOI: 10.1016/j.jhqr.2025.101145
A.M. Al Jaber , A.A.M. Shaheen , A. Albarrati , A.S. Alqahtani , R.F.M. Gwada , H. Alay
Aim
This study aimed to translate and cross-culturally adapt the Self Care of Coronary Heart Disease (CHD) Inventory into Arabic and measure its psychometric properties among Arabic-speaking patients with CHD.
Method
Using Sousa's guidelines on translation, the study assesses the content validity, construct validity, internal consistency, and test–retest reliability of the Arabic version of the Self-Care of Coronary Heart Inventory (SC-CHDI-Ar). A total of 181 patients with CHD were involved in the validity and reliability testing, and a test re-test was conducted with 61 patients at cardiology clinics in Riyadh, Saudi Arabia.
Results
The content validity index of the three subscales of SC-CHDI-Ar was acceptable. Additionally, the SC-CHDI-Ar did not have any floor or ceiling effects. Positive significant correlations were found among the subscales of SC-CHDI-Ar with the Arabic Cardiac Self Efficacy Questionnaire (CSEQ-A) scores. The internal consistency of SC-CHDI-Ar were ranged from (α = 0.70 to 0.95), and the test–retest of the maintenance, management, and confidence subscales were ICC2,1 = 0.86 (95%CI; .70–0.91), 0.76 (95%CI; 0.59–0.85), and 0.76 (95%CI; 0.56– 0.85), respectively.
Conclusion
The SC-CHDII-Ar is an understandable, valid, and reliable instrument for determining the self-care needs of patients with CHD in Saudi Arabia.
{"title":"Cross-cultural adaptation and validation of the Arabic version of self-care of coronary heart disease inventory","authors":"A.M. Al Jaber , A.A.M. Shaheen , A. Albarrati , A.S. Alqahtani , R.F.M. Gwada , H. Alay","doi":"10.1016/j.jhqr.2025.101145","DOIUrl":"10.1016/j.jhqr.2025.101145","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to translate and cross-culturally adapt the Self Care of Coronary Heart Disease (CHD) Inventory into Arabic and measure its psychometric properties among Arabic-speaking patients with CHD.</div></div><div><h3>Method</h3><div>Using Sousa's guidelines on translation, the study assesses the content validity, construct validity, internal consistency, and test–retest reliability of the Arabic version of the Self-Care of Coronary Heart Inventory (SC-CHDI-Ar). A total of 181 patients with CHD were involved in the validity and reliability testing, and a test re-test was conducted with 61 patients at cardiology clinics in Riyadh, Saudi Arabia.</div></div><div><h3>Results</h3><div>The content validity index of the three subscales of SC-CHDI-Ar was acceptable. Additionally, the SC-CHDI-Ar did not have any floor or ceiling effects. Positive significant correlations were found among the subscales of SC-CHDI-Ar with the Arabic Cardiac Self Efficacy Questionnaire (CSEQ-A) scores. The internal consistency of SC-CHDI-Ar were ranged from (<em>α</em> <!-->=<!--> <!-->0.70 to 0.95), and the test–retest of the maintenance, management, and confidence subscales were ICC<sub>2,1</sub> <!-->=<!--> <!-->0.86 (95%CI; .70–0.91), 0.76 (95%CI; 0.59–0.85), and 0.76 (95%CI; 0.56– 0.85), respectively.</div></div><div><h3>Conclusion</h3><div>The SC-CHDII-Ar is an understandable, valid, and reliable instrument for determining the self-care needs of patients with CHD in Saudi Arabia.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101145"},"PeriodicalIF":1.1,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144090505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-16DOI: 10.1016/j.jhqr.2025.101144
M. Miron Rubio , J. Regalado de los Cobos , L. Villegas Bruguera , A. Basterretxea Ozamiz , I. Carrillo Murcia , M. Guilabert Mora , J.J. Mira Solves , M. Santiñà Vila
Introduction and objectives
Home hospitalization has emerged as an effective alternative to traditional hospitalization, especially relevant during the COVID-19 pandemic. However, home hospitalization lacks uniformity in its implementation. This study, conducted by the Spanish Society of Home Hospitalization and the Spanish Society of Healthcare Quality, aims to develop specific quality criteria and an accreditation standard for home hospitalization units.
Materials and methods
The qualitative study, carried out between May 2021 and June 2022, was conducted in 3 phases: literature review, consensus conference, and Delphi technique. The literature review identified existing quality criteria, and the consensus conference defined the areas and dimensions of quality. Using the Delphi technique, 67 national experts refined and reached a consensus on these criteria through 2 rounds of online surveys.
Results
The review identified 240 ideas grouped into 17 categories, and after the consensus conference, 120 initial criteria were proposed, reduced to 54 for the Delphi technique. Finally, 23 quality criteria were agreed upon, 14 considered essential and 9 recommended, covering areas such as accessibility, efficacy, patient safety, integrated care, patient experience, and unit efficiency.
Conclusions
The study provides a consensual quality standard for home hospitalization units in Spain, facilitating self-assessment, accreditation, and continuous improvement. The implementation of these criteria will help standardize home hospitalization, ensure service quality, and promote the expansion of this care model, with the Spanish Society of Home Hospitalization responsible for its dissemination and updating.
{"title":"Criterios y norma de acreditación en calidad para servicios de hospitalización a domicilio: documento de la Sociedad Española de Hospitalización a Domicilio y la Sociedad Española de Calidad Asistencial","authors":"M. Miron Rubio , J. Regalado de los Cobos , L. Villegas Bruguera , A. Basterretxea Ozamiz , I. Carrillo Murcia , M. Guilabert Mora , J.J. Mira Solves , M. Santiñà Vila","doi":"10.1016/j.jhqr.2025.101144","DOIUrl":"10.1016/j.jhqr.2025.101144","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Home hospitalization has emerged as an effective alternative to traditional hospitalization, especially relevant during the COVID-19 pandemic. However, home hospitalization lacks uniformity in its implementation. This study, conducted by the Spanish Society of Home Hospitalization and the Spanish Society of Healthcare Quality, aims to develop specific quality criteria and an accreditation standard for home hospitalization units.</div></div><div><h3>Materials and methods</h3><div>The qualitative study, carried out between May 2021 and June 2022, was conducted in 3 phases: literature review, consensus conference, and Delphi technique. The literature review identified existing quality criteria, and the consensus conference defined the areas and dimensions of quality. Using the Delphi technique, 67 national experts refined and reached a consensus on these criteria through 2 rounds of online surveys.</div></div><div><h3>Results</h3><div>The review identified 240 ideas grouped into 17 categories, and after the consensus conference, 120 initial criteria were proposed, reduced to 54 for the Delphi technique. Finally, 23 quality criteria were agreed upon, 14 considered essential and 9 recommended, covering areas such as accessibility, efficacy, patient safety, integrated care, patient experience, and unit efficiency.</div></div><div><h3>Conclusions</h3><div>The study provides a consensual quality standard for home hospitalization units in Spain, facilitating self-assessment, accreditation, and continuous improvement. The implementation of these criteria will help standardize home hospitalization, ensure service quality, and promote the expansion of this care model, with the Spanish Society of Home Hospitalization responsible for its dissemination and updating.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101144"},"PeriodicalIF":1.1,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144071824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-15DOI: 10.1016/j.jhqr.2025.101143
N. Abed , S.C. Buttigieg , C. Feichtinger , P. Sousa , B. Knezevic , S. Tella , E. Srulovici , N. Bessa Vilela , R. Cohen , K. Põlluste , M. Odalović , V. Klemm , R. Strametz , J.J. Mira
Pub Date : 2025-05-14DOI: 10.1016/j.jhqr.2025.101140
L. Del-Valle Quintana , K. Sichieri , S. Secoli
Background and objective
Design Thinking is a user centered methodology used to address problems through innovation. Patient safety is a complex issue within healthcare and remains a global priority. International organizations urge the development of joint strategies to tackle this challenge. The objective was to map the current use of Design Thinking as a methodology to promote patient safety in healthcare settings.
Materials and methods
A scoping review was conducted following the Joanna Briggs Institute guidelines, using indexed databases such as PubMed, CINAHL, WOS, EMBASE, Scopus, Science Direct, PsycINFO, SciELO, and ERIC, as well as grey literature from CAPES and ProQuest journals. The protocol was registered in Open Science Framework. Data were analyzed and summarized narratively.
Results
A total of 55 publications applying Design Thinking in the context of patient safety were included. The six international patient safety goals were addressed, with a focus on effective communication (45%) and medication safety (35%). The study design was not reported in 65% of the cases, and 30% lacked data procedures and analysis. The healthcare team participated in 93% of the studies, while patients were involved in 44%. The most common solutions were mobile applications, software, and dashboards.
Conclusions
Design Thinking is contributing to improvements in patient safety by developing co-designed solutions, particularly in the international patient safety goals of communication and medication safety. However, the lack of a rigorous methodological approach limits the validity and replicability of the results.
{"title":"Design Thinking y su uso para promover la seguridad de los pacientes: revisión de alcance","authors":"L. Del-Valle Quintana , K. Sichieri , S. Secoli","doi":"10.1016/j.jhqr.2025.101140","DOIUrl":"10.1016/j.jhqr.2025.101140","url":null,"abstract":"<div><h3>Background and objective</h3><div>Design Thinking is a user centered methodology used to address problems through innovation. Patient safety is a complex issue within healthcare and remains a global priority. International organizations urge the development of joint strategies to tackle this challenge. The objective was to map the current use of Design Thinking as a methodology to promote patient safety in healthcare settings.</div></div><div><h3>Materials and methods</h3><div>A scoping review was conducted following the Joanna Briggs Institute guidelines, using indexed databases such as PubMed, CINAHL, WOS, EMBASE, Scopus, Science Direct, PsycINFO, SciELO, and ERIC, as well as grey literature from CAPES and ProQuest journals. The protocol was registered in Open Science Framework. Data were analyzed and summarized narratively.</div></div><div><h3>Results</h3><div>A total of 55 publications applying Design Thinking in the context of patient safety were included. The six international patient safety goals were addressed, with a focus on effective communication (45%) and medication safety (35%). The study design was not reported in 65% of the cases, and 30% lacked data procedures and analysis. The healthcare team participated in 93% of the studies, while patients were involved in 44%. The most common solutions were mobile applications, software, and dashboards.</div></div><div><h3>Conclusions</h3><div>Design Thinking is contributing to improvements in patient safety by developing co-designed solutions, particularly in the international patient safety goals of communication and medication safety. However, the lack of a rigorous methodological approach limits the validity and replicability of the results.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 4","pages":"Article 101140"},"PeriodicalIF":1.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143948760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-14DOI: 10.1016/j.jhqr.2025.101142
S. Hernández-Dorta , I. Izuzquina-Avanzini , A. Lobelle-Seijas , I. Fernández-Uzquiano , L. Ramos-Rúa , J. López-Castro
Introduction
There are numerous studies examining the diagnostic accuracy of various supplementary tests; however, the literature focused on diagnostic accuracy derived from clinical reasoning and data is limited. Consequently, we conducted a study to assess the diagnostic accuracy of the professionals in the Internal Medicine Department at our hospital and to examine whether there are variations in accuracy related to specific pathologies and across different time periods, particularly before and after the emergence of the SARS-CoV-2 pandemic.
Methods
This is a retrospective, longitudinal, and observational study conducted in the Internal Medicine Department of the Regional Hospital of Monforte de Lemos from 2016 to 2022, encompassing both pre- and post-SARS-CoV-2 pandemic periods. The initial diagnosis made upon patient admission was compared with the final diagnosis at discharge through an independent peer review process.
Results
The diagnostic concordance at admission and discharge was 77.4%, with statistically significant differences observed between age groups (with higher concordance in patients under 55 years of age) and according to sex, with greater concordance in female patients. No differences were found regarding pathology type or temporal cohort.
Conclusions
The diagnostic accuracy of the healthcare professionals in the Internal Medicine Department at Monforte Public Hospital during the study periods was found to be high. Diagnostic concordance was greater in female patients and those under 55 years of age, with no significant differences observed across the most prevalent pathological conditions. Furthermore, the restrictive measures implemented during the SARS-CoV-2 pandemic do not appear to have negative affected diagnostic accuracy when compared to previous periods.
有许多研究检查各种补充测试的诊断准确性；然而，文献集中于诊断准确性来源于临床推理和数据是有限的。因此，我们进行了一项研究，以评估我院内科专业人员的诊断准确性，并检查与特定病理相关的准确性是否存在差异，并在不同的时间段内，特别是在SARS-CoV-2大流行出现之前和之后。方法本研究是一项回顾性、纵向和观察性研究，于2016年至2022年在Monforte de Lemos地区医院内科进行，包括sars - cov -2大流行前后的时期。通过独立的同行评审过程，将患者入院时的初步诊断与出院时的最终诊断进行比较。结果入院和出院时诊断符合率为77.4%，不同年龄组（55岁以下患者符合率较高）、不同性别（女性患者符合率较高）差异均有统计学意义。在病理类型和时间队列方面没有发现差异。结论蒙福特公立医院内科医护人员在研究期间的诊断准确率较高。诊断一致性在女性患者和55岁以下患者中更高，在最常见的病理状况中没有观察到显著差异。此外，与以前的时期相比，在SARS-CoV-2大流行期间实施的限制性措施似乎没有对诊断准确性产生负面影响。
{"title":"Analysis of the accuracy of clinical diagnosis in an internal medicine department of a regional hospital: Inter-MONF study","authors":"S. Hernández-Dorta , I. Izuzquina-Avanzini , A. Lobelle-Seijas , I. Fernández-Uzquiano , L. Ramos-Rúa , J. López-Castro","doi":"10.1016/j.jhqr.2025.101142","DOIUrl":"10.1016/j.jhqr.2025.101142","url":null,"abstract":"<div><h3>Introduction</h3><div>There are numerous studies examining the diagnostic accuracy of various supplementary tests; however, the literature focused on diagnostic accuracy derived from clinical reasoning and data is limited. Consequently, we conducted a study to assess the diagnostic accuracy of the professionals in the Internal Medicine Department at our hospital and to examine whether there are variations in accuracy related to specific pathologies and across different time periods, particularly before and after the emergence of the SARS-CoV-2 pandemic.</div></div><div><h3>Methods</h3><div>This is a retrospective, longitudinal, and observational study conducted in the Internal Medicine Department of the Regional Hospital of Monforte de Lemos from 2016 to 2022, encompassing both pre- and post-SARS-CoV-2 pandemic periods. The initial diagnosis made upon patient admission was compared with the final diagnosis at discharge through an independent peer review process.</div></div><div><h3>Results</h3><div>The diagnostic concordance at admission and discharge was 77.4%, with statistically significant differences observed between age groups (with higher concordance in patients under 55 years of age) and according to sex, with greater concordance in female patients. No differences were found regarding pathology type or temporal cohort.</div></div><div><h3>Conclusions</h3><div>The diagnostic accuracy of the healthcare professionals in the Internal Medicine Department at Monforte Public Hospital during the study periods was found to be high. Diagnostic concordance was greater in female patients and those under 55 years of age, with no significant differences observed across the most prevalent pathological conditions. Furthermore, the restrictive measures implemented during the SARS-CoV-2 pandemic do not appear to have negative affected diagnostic accuracy when compared to previous periods.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 5","pages":"Article 101142"},"PeriodicalIF":1.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143947091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号